From unlocking the secrets of the tumor microenvironment to advancing new therapies to FDA approval, MD Anderson researchers are driven by a shared goal to end cancer. As some of the top minds in the world, their groundbreaking research is shaping the future of the field and transforming cancer care.
These breakthroughs are possible because of MD Anderson’s unique research environment, which allows new insights to move...
Scientific discoveries are essential to driving advances in cancer care. From better screening and diagnostic techniques to innovative new...
The route a cancer takes from its earliest stages to advanced disease is a long and winding road. Often, the first mutations or changes that...
First discovered in the 1980s, exosomes are microscopic spherical packages, called vesicles, released by all cells. Their normal role in the body is still being studied, but it is clear to scientists that these virus-sized containers hold a wealth of information about the cells they come from.
Knowing this, researchers are looking to exosomes as tools to screen for cancer, guide treatment strategies and follow how patients respond...
Adoptive cellular therapy is a form of immunotherapy that uses cells from our immune systems, such as T cells, as a treatment for cancer....
Stomach and esophageal cancers are diagnosed in more than 40,000 people each year in the U.S. Most of these cases aren’t detected until the...
Discovering and developing new treatments for cancer is a difficult process with many obstacles. These challenges can slow the process of...
Targeted therapies are designed to work against specific vulnerabilities in a cancer cell.
The targeted therapy drug venetoclax is...
For patients with pancreatic cancer, the benefits from immunotherapy treatments with immune checkpoint inhibitors or cell therapies have been...
Last updated on Dec. 9, 2022
Immunotherapy is a treatment option for a growing number of cancers. Unlike traditional treatments like...